ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

DCPC Board Objects To Cutting Grants Each Award Year

February 17, 1989

Without Advance Directives, Families Prolong Treatment

April 27, 2001

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

NCI budget: a “Yes” to one thing means a “No” to something else, director says.

February 27, 2004

Cancer Meetings Listed

April 15, 1994

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001